NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NEI E-192-2014-1-CH-01 Surgical Tool and Method for Ocular Tissue Transplantation CH EP 15741462.4 Issued
NEI E-192-2014-1-GB-01 Surgical Tool and Method for Ocular Tissue Transplantation GB EP 15741462.4 Issued
NEI E-192-2014-1-FR-01 Surgical Tool and Method for Ocular Tissue Transplantation FR EP 15741462.4 Issued
NEI E-192-2014-1-DE-01 Surgical Tool and Method for Ocular Tissue Transplantation DE EP 15741462.4 Issued
NEI E-192-2014-1-IN-06 Surgical Tool and Method for Ocular Tissue Transplantation IN National Stage 201717003244 Issued
NEI E-192-2014-1-PCT-01 Surgical Tool and Method for Ocular Tissue Transplantation PCT PCT COMB PCT/US2015/039932 Expired
NEI E-192-2014-1-AU-03 Surgical Tool and Method for Ocular Tissue Transplantation AU National Stage 2015287692 Abandoned
NCI E-227-2015-0-US-01 Enhancing Astrocyte Neuroprotective Functions Using P53 Isoforms US 62/190,644 Abandoned
NCI E-136-2014-1-US-01 CONSTANT DOMAIN ANTIBODY SCAFFOLDS US 62/190,586 Abandoned
NCI E-159-2014-0-PCT-02 Polyketal Particles Including a CPG Oligodeoxynucleotide for the Treatment of Lung Cancer PCT PCT PCT/US2015/039574 Expired
NCATS E-282-2015-0-GB-01 NOVEL TRICYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER GB ORD 1514018.9 Abandoned
NCATS E-283-2015-0-GB-01 NOVEL PYRIDAZINONES AND THEIR USE IN THE TREATMENT OF CANCER GB ORD 1514015.5 Abandoned
NCI E-174-2012-0-US-02 Methods of Producing T Memory Stem Cell Populations US National Stage 14/425,713 10316289 Issued PDF
NINDS E-143-2002-1-US-44 Zenapax (Humanized Antibody Against The IL-2 Receptor Alpha Chain) As A Novel Treatment For Multiple Sclerosis14/792,432 US CON 14/792,432 Abandoned
NIAID E-076-2015-3-US-01 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION US 62/189,109 Abandoned
NIEHS E-292-2015-0-US-01 Methods And Composition For Treating Nephropathy US 62/188,544 Abandoned
NIMH E-448-2013-0-US-03 Antineuronal Antibodies In Pediatric Acute Neurologic Syndrome For Diagnosis And Treatment US CON 14/790,416 Abandoned
NIAID E-139-2006-0-IN-26 Development Of Dengue Virus Vaccine Components IN DIV 5799/DELNP/2015 Issued
NHLBI E-157-2019-0-US-02 IMPLANTED MAGNETS RETRIEVAL SYSTEM AND METHOD US ORD 14/788,920 9943335 Issued PDF
NCATS E-061-2017-0-PCT-02 O-GlcNAc Transferase (OGT) Inhibitors And Uses Thereof PCT PCT PCT/US15/038792 Expired
NIDA E-049-2015-0-US-01 A Mobile Health Platform US 62/186,983 Abandoned
NCI E-033-2008-0-US-08 Therapeutic Applications Of A P53 Isoform In Regenerative Medicine, Aging And Cancer US DIV 14/754,000 9944927 Issued PDF
NHGRI E-217-2007-0-US-10 N-acetyl Mannosamine as a Therapeutic Agent US CON 14/754,304 Abandoned
NCI E-193-2015-0-US-01 Methods of Characterizing Adrenocortical Tumors US 62/186,218 Abandoned
NCI E-198-2014-0-PCT-02 Detection Of Colorectal Cancer With Two Novel Heme-related Molecules In Human Feces PCT PCT PCT/US15/038299 Expired
NIAID E-120-2001-0-AU-86 Development of Mutations Useful for Attenuating Dengue Viruses and Chimeric Dengue Viruses AU DIV 2015203575 Expired
NCATS E-043-2013-0-JP-06 Inhibitors of the USP1/UAF1 Deubiquitinase Complex and Uses Thereof JP National Stage 2015-550767 Pending
NCI E-235-2015-0-US-01 Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers US 62/185,265 Abandoned
NCATS E-043-2013-0-US-07 Inhibitors Of The USP1/UAF1 Deubiquitinase Complex and Uses Thereof US National Stage 14/655,538 9802904 Issued PDF
NCI E-148-2015-0-US-01 Biomarkers for NAD(+)-Diphathamide ADP Ribosyl Transferase Sensitivity and Resistance US 62/183,900 Abandoned
NIA E-045-2012-0-US-03 THIO COMPOUNDS US CON 14/746,512 9623020 Issued PDF
NIBIB E-143-2015-0-US-01 Chemical Conjugation Of Evans Blue Derivatives and Their Use in The Production of Long-Acting Therapeutics US 62/182,694 Abandoned
NINDS E-046-2015-1-PCT-01 LB-100 Enhances The Effectiveness Of DNA-damaging Anti-cancer Drugs Against Cancer Cells Which Show Multi-drug Resistant MDR Phenotype PCT PCT PCT/US2015/036693 Expired
NINDS E-046-2015-1-EP-02 LB-100 Enhances The Effectiveness Of DNA-damaging Anti-cancer Drugs Against Cancer Cells Which Show Multi-drug Resistant MDR Phenotype EP National Stage 15809386.4 Abandoned
NIAID E-209-2016-0-US-01 Single Domain Antibody Against RSV F Protein US 62/181,522 Abandoned
NICHD E-223-2015-0-US-01 AUTOPHAGIC INDUCERS FOR TREATING NEURODEGENERATIVE DISEASES US 62/181,628 Abandoned
NLM E-111-2016-0-US-01 Novel CRISPR Enzymes And Systems US 62/181,675 Abandoned
NLM E-110-2016-0-US-01 Novel CRISPR Enzymes And Systems US 62/181,663 Abandoned
NIAID E-139-2006-0-US-25 Development Of Dengue Virus Vaccine Components US DIV 14/742,533 10160957 Issued PDF
NICHD E-016-2013-2-GB-08 Assay to Measure Midkine or Pleiotrophin Level for Diagnosing a Growth GB EP 13798508.1 Issued
NICHD E-016-2013-2-DE-06 Assay to Measure Midkine or Pleiotrophin Level for Diagnosing a Growth DE EP 13798508.1 Issued
NICHD E-016-2013-2-FR-07 Assay to Measure Midkine or Pleiotrophin Level for Diagnosing a Growth FR EP 13798508.1 Issued
NCATS E-026-2016-1-US-01 Kinetin Derivatives US 62/180,380 Abandoned
NINDS E-309-2009-1-US-07 Magnetic Microstructures For Magnetic Resonance Imaging US DIV 14/739,813 1022-01-03 Issued PDF
NHLBI E-133-2014-0-IE-09 Blocking CD38 Using Anti-CD38 Fab2 To Protect NK Cells IE EP 15747597.1 Issued
NHLBI E-133-2014-0-DE-06 Blocking CD38 Using Anti-CD38 Fab2 To Protect NK Cells DE EP 15747597.1 Issued
NHLBI E-133-2014-0-FR-07 Blocking CD38 Using Anti-CD38 Fab2 To Protect NK Cells FR EP 15747597.1 Issued
NHLBI E-133-2014-0-CH-05 Blocking CD38 Using Anti-CD38 Fab2 To Protect NK Cells CH EP 15747597.1 Issued
NHLBI E-133-2014-0-GB-08 Blocking CD38 Using Anti-CD38 Fab2 To Protect NK Cells GB EP 15747597.1 Issued
NHLBI E-133-2014-0-EP-04 Blocking CD38 Using Anti-CD38 Fab2 To Protect NK Cells EP National Stage 15747597.1 Issued